CORR Insights®: Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomize...
CORR Insights®: Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial
About this item
Full title
CORR Insights®: Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial
Author / Creator
Publisher
New York: Springer US
Journal title
Clinical orthopaedics and related research, 2016-12, Vol.474 (12), p.2712-2713
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Alternative Titles
Full title
CORR Insights®: Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5085950
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5085950
Other Identifiers
ISSN
0009-921X
E-ISSN
1528-1132
DOI
10.1007/s11999-016-5082-y
